SEARCH

SEARCH BY CITATION

References

  • 1
    Ramer LM, Au E, Richter MW et al. Peripheral olfactory ensheathing cells reduce scar and cavity formation and promote regeneration after spinal cord injury. J Comp Neurol 2004; 473:115.
  • 2
    Pearse DD, Marcillo AE, Oudega M et al. Transplantation of Schwann cells and olfactory ensheathing glia after spinal cord injury: Does pretreatment with methylprednisolone and interleukin-10 enhance recovery? J Neurotrauma 2004; 21:12231239.
  • 3
    Ogawa Y, Sawamoto K, Miyata T et al. Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J Neurosci Res 2002; 69:925933.
  • 4
    Koshizuka S, Okada S, Okawa A et al. Transplanted hematopoietic stem cells from bone marrow differentiate into neural lineage cells and promote functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol 2004; 63:6472.
  • 5
    Munoz-Elias G, Woodbury D, Black IB. Marrow stromal cells, mitosis, and neuronal differentiation: Stem cell and precursor functions. Stem Cells 2003; 21:437448.
  • 6
    Sanchez-Ramos J, Song S, Cardozo-Pelaez F et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 2000; 164:247256.
  • 7
    Ha Y, Yoon DH, Yeon DS et al. Neural antigen expressions in cultured human umbilical cord blood stem cells in vitro. J of Kor Neurosurg Soc 2001; 30:963.
  • 8
    Chopp M, Zhang XH, Li Y et al. Spinal cord injury in rat: Treatment with bone marrow stromal cell transplantation. Neuroreport 2000; 11:30013005.
  • 9
    Akiyama Y, Radtke C, Kocsis JD. Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci 2002; 22:66236630.
  • 10
    Kawada H, Takizawa S, Takanashi T et al. Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 2006; 113:701710.
  • 11
    Chen Q, Long Y, Yuan X et al. Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors. J Neurosci Res 2005; 80:611619.
  • 12
    Feron F, Perry C, Cochrane J et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain 2005; 128:29512960.
  • 13
    Huang H, Chen L, Wang H et al. Safety of fetal olfactory ensheathing cell transplantation in patients with chronic spinal cord injury. A 38-month follow-up with MRI. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2006; 20:439443.
  • 14
    Park HC, Shim YS, Ha Y et al. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng 2005; 11:913922.
  • 15
    Grasso G, Sfacteria A, Passalacqua M et al. Erythropoietin and erythropoietin receptor expression after experimental spinal cord injury encourages therapy by exogenous erythropoietin. Neurosurgery 2005; 56:821827.
  • 16
    Gibson CL, Jones NC, Prior MJ et al. G-CSF suppresses edema formation and reduces interleukin-1beta expression after cerebral ischemia in mice. J Neuropathol Exp Neurol 2005; 64:763769.
  • 17
    Brines M, Grasso G, Fiordaliso F et al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci U S A 2004; 101:1490714912.
  • 18
    Bouhy D, Malgrange B, Multon S et al. Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages. FASEB J 2006; 20:12391241.
  • 19
    Ha Y, Kim YS, Cho JM et al. Granulocyte macrophage colony stimulating factor (GM-CSF) prevents apoptosis and improves functional outcome in experimental spinal cord contusion injury. J Neurosurg 2005; 11:5561.
  • 20
    Macias MY, Syring MB, Pizzi MA et al. Pain with no gain: Allodynia following neural stem cell transplantation in spinal cord injury. Exp Neurol 2006; 201:335348.
  • 21
    Hofstetter CP, Holmstrom NA, Lilja JA et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci 2005; 8:346353.
  • 22
    Luck R, Klempnauer J, Steiniger B. Simultaneous occurrence of graft-versus-host and host-versus-graft reactions after allogenic MHC class II disparate small bowel transplantation in immunocompetent rats. Transplant Proc 1991; 23:677678.
  • 23
    Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432:324331.
  • 24
    Ankeny DP, McTigue DM, Jakeman LB. Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp Neurol 2004; 190:1731.
  • 25
    Prewitt CM, Niesman IR, Kane CJ et al. Activated macrophage/microglial cells can promote the regeneration of sensory axons into the injured spinal cord. Exp Neurol 1997; 148:433443.
  • 26
    Knoller N, Auerbach G, Fulga V et al. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: Phase I study results. J Neurosurg Spine 2005; 3:173181.
  • 27
    Beattie MS. Inflammation and apoptosis: Linked therapeutic targets in spinal cord injury. Trends Mol Med 2004; 10:580583.
  • 28
    Gonzalez R, Glaser J, Liu MT. Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury. Exp Neurol 2003; 184:456463.
  • 29
    Dame JB, Chegini N, Christensen RD et al. The effect of interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) on granulocyte macrophage-colony stimulating factor (GM-CSF) production by neuronal precursor cells. Eur Cytokine Netw 2002; 13:128133.
  • 30
    Ha Y, Kim YS, Cho JM et al. Role of granulocyte-macrophage colony-stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury. J Neurosurg Spine 2005; 2:5561.
  • 31
    Tolcher AW, Giusti RM, O'Shaughnessy J et al. Arterial thrombosis associated with granulocyte-macrophage colony-stimulating factor (GM-CSF) administration in breast cancer patients treated with dose-intensive chemotherapy: A report of two cases. Cancer Invest 1995; 13:188192.
  • 32
    Short DJ, El Masry WS, Jones PW. High dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective. Spinal Cord 2000; 38:273286.
  • 33
    McCutcheon EP, Selassie AW, Gu JK et al. Acute traumatic spinal cord injury, 1993–2000. A population-based assessment of methylprednisolone administration and hospitalization. J Trauma 2004; 56:10761083.
  • 34
    Okano H, Ogawa Y, Nakamura M et al. Transplantation of neural stem cells into the spinal cord after injury. Semin Cell Dev Biol 2003; 14:191198.
  • 35
    Hofstetter CP, Schwarz EJ, Hess D et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 2002; 99:21992204.
  • 36
    Lima C, Pratas-Vital J, Escada P et al. Olfactory mucosa autografts in human spinal cord injury: A pilot clinical study. J Spinal Cord Med 2006; 29:191203.
  • 37
    Dobkin BH, Curt A, Guest J. Cellular transplants in China: Observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil Neural Repair 2006; 20:513.
  • 38
    Sykova E, Homola A, Mazanec R et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 2006; 15:675687.
  • 39
    Marino RJ, Ditunno JFJ, Donovan WH et al. Neurologic recovery after traumatic spinal cord injury: Data from the Model Spinal Cord Injury Systems. Arch Phys Med Rehabil 1999; 80:13911396.